Botulinum toxin A for myofascial pain syndrome: a review of the clinical effectiveness
CADTH
Record ID 32015000152
English
Authors' recommendations:
One meta-analysis, two systematic reviews, and four randomized-controlled trials were included in this review. The current available evidence to support the use of botulinum toxin A in the treatment of myofascial pain syndrome is inconclusive.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.cadth.ca/media/pdf/htis/dec-2014/RC0591%20Botox%20for%20Myofascial%20Pain%20Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Humans
- Botulinum Toxins, Type A
- Myofascial Pain Syndromes
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.